USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
Abstract Abnormal alternative splicing (AS) caused by alterations in spliceosomal factors is implicated in cancers. Standard models posit that splice site selection is mainly determined by early spliceosomal U1 and U2 snRNPs. Whether and how other mid/late-acting spliceosome components such as USP39...
Main Authors: | Jingyi Zheng, Shasha Wu, Mao Tang, Shaoyan Xi, Yanchen Wang, Jun Ren, Hao Luo, Pengchao Hu, Liangzhan Sun, Yuyang Du, Hui Yang, Fenfen Wang, Han Gao, Ziwei Dai, Xijun Ou, Yan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-10-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-06210-3 |
Similar Items
-
USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
by: Tanuza Das, et al.
Published: (2022-01-01) -
UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
by: Yanchen Wang, et al.
Published: (2023-06-01) -
The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor
by: Xiaolin Zhu, et al.
Published: (2022-05-01) -
SRSF2 is required for mRNA splicing during spermatogenesis
by: Wen-Long Lei, et al.
Published: (2023-10-01) -
SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing
by: Wenbo Liu, et al.
Published: (2022-11-01)